Cargando…

P1366: SAR442257, A CD38/CD28/CD3 TRISPECIFIC ANTIBODY, POTENTIATES CAR T-CELL ACTIVITY AGAINST LARGE B-CELL LYMPHOMA

Detalles Bibliográficos
Autores principales:	Reville, Patrick, Dai, Enyu, Sheikh, Irtiza, Deng, Qing, Henderson, Jared, Le, Cuong, Rojas, Estela, Okwuchi, Chizitara, Wilson, Ashley, Parsons, Sydney, Lockman, Shyanne, Kim, Peter, Bisht, Kamlesh, van de Velde, Helgi, Wang, Hongfang, Neelapu, Sattva, Wang, Linghua, Green, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430625/ http://dx.doi.org/10.1097/01.HS9.0000972352.86009.7f

Ejemplares similares

CXCR5+CD8+ T cells are localized in B cell follicles and germinal centers and exhibit regulatory and anti-tumor function
por: Chu, Fuliang, et al.
Publicado: (2015)

Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity
por: Schmohl, Jörg U., et al.
Publicado: (2017)

Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
por: Bisht, Kamlesh, et al.
Publicado: (2023)

Trispecific killer engager 161519 enhances natural killer cell function and provides anti-tumor activity against CD19-positive cancers
por: Cheng, Ying, et al.
Publicado: (2020)

A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy
por: Liu, Dong, et al.
Publicado: (2022)

1366. Microbiology of Acute Hematogenous Osteomyelitis in Hospitalized Children
por: Hu, Nina, et al.
Publicado: (2020)

1366. Re-examining the Origins of Ebola virus Emergence
por: Judson, Seth D
Publicado: (2022)

Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses
por: Romain, Gabrielle, et al.
Publicado: (2022)

Targeting B cell malignancies through human B cell receptor specific CD4 T cells
por: Weng, Jinsheng, et al.
Publicado: (2015)

Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy
por: Au, Kin Man, et al.
Publicado: (2020)

Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells
por: Strati, Paolo, et al.
Publicado: (2023)

1366P Impact of COVID-19 on prostate cancer diagnosis and treatment
por: Leszczynski, R.L., et al.
Publicado: (2022)

Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model
por: Mueller-Schoell, Anna, et al.
Publicado: (2021)

Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas
por: Chu, Fuliang, et al.
Publicado: (2023)

Absence of Grail promotes CD8(+) T cell anti-tumour activity
por: Haymaker, Cara, et al.
Publicado: (2017)

Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer
por: Tapia-Galisteo, Antonio, et al.
Publicado: (2022)

Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
por: Tapia-Galisteo, Antonio, et al.
Publicado: (2023)

S259: SAR444245, A NON-ALPHA IL2, RESCUES CHRONIC ANTIGEN- AND CAR-DRIVEN T-CELL DYSFUNCTION
por: Sheikh, Irtiza, et al.
Publicado: (2023)

1366. In Vitro and In Vivo Activity of Cefiderocol against Stenotrophomonas maltophilia Clinical Isolates
por: Ito, Akinobu, et al.
Publicado: (2018)

CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
por: Plaks, Vicki, et al.
Publicado: (2021)

Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
por: Cai, Tianyu, et al.
Publicado: (2022)

Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma
por: Cherng, Hua-Jay J., et al.
Publicado: (2022)

Regulation of CD4(+)CD8(−)CD25(+) and CD4(+)CD8(+)CD25(+) T cells by gut microbiota in chicken
por: Lee, In Kyu, et al.
Publicado: (2018)

When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy
por: Tapia-Galisteo, Antonio, et al.
Publicado: (2023)

T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA
por: van de Donk, Niels W.C.J., et al.
Publicado: (2023)

CXCR5(+)CD8(+) T cells are a distinct functional subset with antitumor activity
por: Chu, Fuliang, et al.
Publicado: (2019)

Early cellular events and potential regulators of cellulase induction in Penicillium janthinellum NCIM 1366
por: Christopher, Meera, et al.
Publicado: (2023)

$^{120}$Cd and $^{122}$Cd
por: Scheidemann, Ø, et al.
Publicado: (1973)

CD3, CD4, CD8, CD19 and CD16/CD56 positive cells in tuberculosis infection and disease: Peculiar features in children
por: Venturini, Elisabetta, et al.
Publicado: (2019)

Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1(+) T-cell subsets
por: Chu, Fuliang, et al.
Publicado: (2014)

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
por: Rothenberger, Sylvia, et al.
Publicado: (2022)

Value of CD16/CD66b/CD45 in comparison to CD55/CD59/CD45 in diagnosis of paroxysmal nocturnal haemoglobinuria: An Indian experience
por: Kotru, Mrinalini, et al.
Publicado: (2017)

CD3+, CD56+, CD4−, CD8−, CD20−, CD30− Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report
por: Jagati, Ashish, et al.
Publicado: (2017)

Tyrosine phosphorylation of CD6 by stimulation of CD3: augmentation by the CD4 and CD2 coreceptors
Publicado: (1993)

CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation
por: Sekerkova, Alena, et al.
Publicado: (2014)

Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia
por: Alvarez-Larrán, Alberto, et al.
Publicado: (2023)

Percentages of CD4+CD161+ and CD4−CD8−CD161+ T Cells in the Synovial Fluid Are Correlated with Disease Activity in Rheumatoid Arthritis
por: Miao, Jinlin, et al.
Publicado: (2015)

CD160 isoforms and regulation of CD4 and CD8 T-cell responses
por: El-Far, Mohamed, et al.
Publicado: (2014)

Diagnostic Challenges of CD4(+)/CD56(+)/CD123(+) hematological neoplasms
por: Thiago, Leandro S., et al.
Publicado: (2013)

CD3(+)CD8(+)CD28(−) T Lymphocytes in Patients with Lupus Nephritis
por: Żabińska, Marcelina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4qcr3b8goidj6hginio2loj3tu